Background -High neural drive to the respiratory muscles and rapid and shallow breathing are frequently observed in patients with chronic obstructive pulmonary disease (COPD), and both mechanical and chemical factors are thought to play a part. However, the interrelation between these factors and the modifications in the control of breathing are not clearly defined. PPLmax ratios, appears to be the major determinant of changes in breathing pattern and inspiratory muscle activity (decrease in EMG).
Abstract
Background -High neural drive to the respiratory muscles and rapid and shallow breathing are frequently observed in patients with chronic obstructive pulmonary disease (COPD), and both mechanical and chemical factors are thought to play a part. However, the interrelation between these factors and the modifications in the control of breathing are not clearly defined. The effects of an acute decrease in mechanical load by the administration of a high dose of a l2 agonist were studied. Methods -Nine spontaneously breathing patients with severe COPD took part in the study. Criteria for entry were FEVy of <40% of predicted and an improvement in FEVy of <200 ml after inhalation of 400 tg fenoterol. The following parameters were measured: lung volumes, tidal volume (VT), respiratory frequency (Rf), maximal pleural pressure during a sniff manoeuvre (PPLmax), pleural pressure swings (PPLSW), lung resistance (RL), RI/ PPLmax ratio, and surface electromyographic activity (EMG) of diaphragm (EDI) and parasternal (EPS) muscles. Arterial oxygen saturation (Sao,), end tidal carbon dioxide pressure (PETCo2), and the electrocardiogram were also monitored. Each variable was measured under control conditions and 20 method'9; RL/PPLmax ratio was also calculated and represented the balance between the mechanical impediment to breathing and the ability of inspiratory muscles to develop force. The tension time index of the inspiratory muscles was calculated as the product of Ti/ TTOT x PPLsw/PPLmax. Mouth pressure during tidal breathing was measured using a pressure transducer (Statham P23ID).
The electromyographic activity (EMG) of the inspiratory muscles was recorded using a method previously described.202' Electromyographic activity of parasternal muscles (EPs) was recorded from the second to third intercostal spaces parasternally and that of the diaphragm (EDI) from the lower anterolateral rib cage, from the sixth to seventh intercostal space on the midclavicular line, via large surface electrodes. Muscle action potentials ("raw") were differentially amplified, filtered between 100 and 1000 Hz. The filtered EMG signal along with mouth pressure recording were displayed on a single beam storage oscilloscope (Tektronix 5115). EMG activity was full wave rectified and integrated over time (time constant 100 ms) using a third order, low pass filter to provide a measurement of change in average electrical activity as a function of time, referred to as "moving time average".22 24 Inspiratory activity was quantified both as peak activity and as rate of rise (slope). The former was directly measured in arbitrary units and the latter obtained by dividing this value by the relevant inspiratory time. Because of the variability of the impedance between inspiratory muscles and electrodes, absolute values (mV) are not comparable between different subjects. To overcome this problem and to obtain a reference value, EMG activity was measured whilst the subject performed an inspiratory capacity (IC) manoeuvre up to TLC connected to the pneumotachograph.25 This manoeuvre was repeated at least three times and in each subject both IC and the intensity of the recorded parastemal and diaphragmatic EMG was reproducible (less than 5% variability). The maximal level of this EMG activity was taken as a reference and the successive measurements have been expressed as a percentage of this value at TLC. As the inhalation of 12 agonists could induce changes in lung volumes and in chest wall configuration, each patient performed TLC manoeuvres twice -first under control conditions and second after the inhalation of fenoterol. Thus, for each phase of the experiment EMG measurements were expressed as a percentage of the relevant value recorded at TLC. As EMG activity of an inspiratory muscle may include cardiac muscle activity, we checked cardiac artifacts to a manually gated ECG, when necessary, so that it would not contribute to the EMG.
The output of the carbon dioxide meter, flow signal, integrated flow signal, mouth pressure, oesophageal pressure, and the moving time average of both diaphragm and parasternal muscles were recorded continuously on a multichannel chart recorder (Gould TA4000).
PROTOCOL
On a pre-intervention day subjects underwent blood eosinophil count and baseline spirometric testing and the response to 400 jig fenoterol was measured. Patients fulfilling the 
INSPIRATORY MUSCLE STRENGTH MEASUREMENTS
The patients had reduced inspiratory muscle strength with a low value of PPLmax, and a small but significant increase was observed both pressure swings during tidal breathing, and high activity of inspiratory muscles as assessed by electromyographic activity of both parasternal and diaphragm muscles. Airflow obstruction plays an important part in determining these alterations, as significant changes were measured after inhalation of a large dose of fenoterol. Decreased inspiratory muscle strength is common in patients with COPD, particularly when there is accompanying hyperinflation. The reduction in maximal inspiratory pressure Fenoterol induced small but significant changes in the breathing pattern (increase in VT and reduction in RJ). In order to achieve the increased mechanical load a higher pressure must be developed with each breath and, in the presence of the reduced inspiratory muscle strength (increased RL/PPLmax ratio), a high proportion of the available force will be used at each breath (high PPLsw/PiLmax ratio). In these conditions central respiratory activity is directed towards a shallower pattern of breathing and an increase in respiratory frequency, the latter offsetting the reduction in VT and allowing VE to remain in the normal range.8 Fenoterol induced significant changes in both VT (increase) and Rf (decrease), which related to changes in PPLSW (%PPLmax) and RL/ PPLmax ratio but not to changes in either RL or FEV1. Consistent with the hypothesis of Rochester,8 these findings indicate that it is the ratio between the mechanical load and the available strength rather than the mechanical load itself which determines the pattern of breathing.
Patients with COPD have a high neural inspiratory drive compared with normal subjects."1A Our patients showed high values of EMG activity of both diaphragm and intercostal muscles and this suggests that a high neural inspiratory drive was present. This conclusion may be correct if one considers the EMG activity of the inspiratory muscles to be a reliable index of neural inspiratory drive. We have criticised the use of either surface or oesophageal EMG recordings for assessing neural drive in humans.4203' However, a close correlation between changes in electrical activity of the phrenic nerve and the diaphragm has been reported in dogs, during both normal breathing and obstructed breathing,32 and data are available to support the contention that the slope of the "moving time average" is a reliable measure for assessing neural inspiratory drive to the respiratory muscles both in normal and in disease states.42021 24 31 The close relationship between EMG and PPLSW further supports the hypothesis that surface EMG of inspiratory muscles may be a useful tool for evaluating inspiratory muscle activation for clinical purposes. Both mechanical (pulmonary and chest wall)'67 and chemical afferents'9 may be involved in the increased neural inspiratory drive observed in our patients. Fenoterol induced a marked decrease in EDI and EPs in terms of both peak (49-5% and 46-62%, respectively) and slope (63-05% and 6002%, respectively) activity. The close relationship between decrease in either PPLSW or RL/PPLmax ratio and decrease in EMG activity of both diaphragm and parasternal muscles (table 4) supports the hypothesis that mechanical impairment has an important role in determining the increase in inspiratory neural drive. Chemical factors may also play a part, as shown by the significant relationship between changes in PETCO2 and changes in EDITi and EPsITi.
In conclusion, in patients with severe COPD high doses of fenoterol induce a significant decrease in total lung resistance and a concomitant decrease in PPLSw and in PPLSW/ PPLmax. Decrease in inspiratory muscle loading relative to the maximal available strength, as expressed by the RL/PPLmax and PPLSW/ PPLmax ratios, appears to be the major determinant of both changes in breathing pattern and decrease in inspiratory muscle activation. These findings may be of clinical relevance since P2 agonists at high doses may induce a significant improvement in respiratory mechanics with minor cardiac side effects.
